Inactive Instrument

Perrigo Company Share Price Nasdaq

Equities

US7142901039

Pharmaceuticals

End-of-day quote Nasdaq
- USD - Intraday chart for Perrigo Company
Sales 2024 * 4.62B 369B Sales 2025 * 4.83B 386B Capitalization 4.19B 334B
Net income 2024 * -74M -5.91B Net income 2025 * 106M 8.47B EV / Sales 2024 * 1.6 x
Net Debt 2024 * 3.21B 256B Net Debt 2025 * 3.01B 241B EV / Sales 2025 * 1.49 x
P/E ratio 2024 *
-21.2 x
P/E ratio 2025 *
192 x
Employees -
Yield 2024 *
3.59%
Yield 2025 *
3.82%
Free-Float 99.69%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 55 29/06/23
Director of Finance/CFO 49 15/05/22
Chief Tech/Sci/R&D Officer - 31/12/14
Members of the board TitleAgeSince
Chairman 55 14/12/20
Director/Board Member 68 05/02/17
Director/Board Member 67 05/02/17
More insiders
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Calendar
More about the company